Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Femke B.G. Lamers-Karnebeek; Jolanda J. Luime; Tim L. Jansen; Piet L.C.M. Van Riel; Johannes W.G. Jacobs

doi:10.1093/rheumatology/kez488

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Femke B.G. Lamers-Karnebeek, Jolanda J. Luime, Tim L. Jansen, Piet L.C.M. Van Riel, Johannes W.G. Jacobs^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1170-1171
Number of pages	2
Journal	Rheumatology (United Kingdom)
Volume	59
Issue number	5
DOIs	https://doi.org/10.1093/rheumatology/kez488
Publication status	Published - 1 May 2020

Access to Document

10.1093/rheumatology/kez488Licence: CC BY-NC

kez488Final published version, 118 KBLicence: CC BY-NC

Cite this

Lamers-Karnebeek, F. B. G., Luime, J. J., Jansen, T. L., Van Riel, P. L. C. M., & Jacobs, J. W. G. (2020). Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial. Rheumatology (United Kingdom), 59(5), 1170-1171. https://doi.org/10.1093/rheumatology/kez488

@article{67766e87662d45f98ffd03146dcf0ed3,

title = "Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial",

author = "Lamers-Karnebeek, {Femke B.G.} and Luime, {Jolanda J.} and Jansen, {Tim L.} and {Van Riel}, {Piet L.C.M.} and Jacobs, {Johannes W.G.}",

year = "2020",

month = may,

day = "1",

doi = "10.1093/rheumatology/kez488",

language = "English",

volume = "59",

pages = "1170--1171",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "5",

}

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial. / Lamers-Karnebeek, Femke B.G.; Luime, Jolanda J.; Jansen, Tim L. et al.
In: Rheumatology (United Kingdom), Vol. 59, No. 5, 01.05.2020, p. 1170-1171.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

AU - Lamers-Karnebeek, Femke B.G.

AU - Luime, Jolanda J.

AU - Jansen, Tim L.

AU - Van Riel, Piet L.C.M.

AU - Jacobs, Johannes W.G.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85084167774&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kez488

DO - 10.1093/rheumatology/kez488

M3 - Comment/Letter to the editor

C2 - 31652321

AN - SCOPUS:85084167774

SN - 1462-0324

VL - 59

SP - 1170

EP - 1171

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 5

ER -

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Access to Document

Other files and links

Cite this